PROs Offer Survival Insights in Patients Undergoing Immunotherapy for Advanced NSCLC

Patient-reported outcomes (PROs) have better prognostic performance for overall survival (OS) and progression-free survival (PFS) compared with physician-defined Eastern Cooperative Oncology Group performance status (ECOG PS) in patients with…

Continue Reading